The Latest Medical Devices Articles from Streetwise Reports


MRI Device Maker's Earnings Come In at High End of Forecasts

Research Report
  ()
IRadimed Corp. reported Q2/22 financial results that were modestly higher than expected. ROTH Capital Partners LLC advised in a research update that based on the company's higher revenues, improved margins, and disciplined cost control measures it is maintaining its Buy rating on IRadimed and raising its price target to $42/share (up from $40).

Medical Device Firm Maintains Growth Momentum in Q2/22

Research Report
  ()
electroCore Inc.'s Q2/22 and H1/22 revenues are up quarter over quarter and year over year, respectively, and the upward trend is expected to continue through year-end 2022, noted an H.C. Wainwright & Co. report.

Trial Shows Colon Cleansing Device to Be Effective

Research Report
  ()
"The positive results could drive physician adoption when scheduling colonoscopies for hard-to-prepare patients going forward," noted an H.C. Wainwright & Co. report.

Medical Device Co. Changes Tack to Drive Topline Growth

Research Report
  ()
This medical device company is improving its laser ablation system and working toward U.S. approval for its use in a second application, noted a Ladenburg Thalmann report.

Co. to Rebound After Q4/21 Sales Down Due to Virus Surge

Research Report
  ()
The 2022 outlook for a cancer detection and therapy solutions company is positive given its focus on dermatology and implementing new commercial strategies, noted an Oppenheimer report.

Showing Results: 1 to 14 of 14

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts